Cargando…
Retraction: Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation via inactivating the AKT signaling pathway
Retraction of ‘Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation via inactivating the AKT signaling pathway’ by Dingmei Deng et al., RSC Adv., 2019, 9, 20385–20394, DOI: 10.1039/C9RA00016J.
Autor principal: | Fisher, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031743/ https://www.ncbi.nlm.nih.gov/pubmed/35481960 http://dx.doi.org/10.1039/d1ra90114a |
Ejemplares similares
-
Retracted Article: Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation via inactivating the AKT signaling pathway
por: Deng, Dingmei, et al.
Publicado: (2019) -
Retraction: miR-199a-3p knockdown inhibits dedifferentiated liposarcoma (DDLPS) cell viability and enhances apoptosis through targeting casein kinase-1 alpha (CK1α)
por: Fisher, Laura
Publicado: (2021) -
Exosomal MiR-199a-5p Inhibits Tumorigenesis and Angiogenesis by Targeting VEGFA in Osteosarcoma
por: Zhang, Lu, et al.
Publicado: (2022) -
MiR-199 Aggravates Doxorubicin-Induced Cardiotoxicity by Targeting TAF9b
por: Yu, Yangsheng, et al.
Publicado: (2022) -
Retraction: Knockdown of TUG1 aggravates hypoxia-induced myocardial cell injury via regulation of miR-144-3p/Notch1
por: Fisher, Laura
Publicado: (2021)